ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,098Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 439

$523K Total Retail Price of All Prescriptions

Rank: 64 out of 439

690 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

3% of this provider’s 690 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 9,121 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $103 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
SIMVASTATIN 532 441 1 3
WARFARIN SODIUM 468 381 2 10
FUROSEMIDE 456 313 3 5
CARVEDILOL 382 288 4 8
LEVOTHYROXINE SODIUM 370 325 5 9
LISINOPRIL 367 313 6 4
AMLODIPINE BESYLATE 356 332 7 2
LOSARTAN POTASSIUM 338 278 8 31
CLOPIDOGREL 312 260 9 16
METOPROLOL TARTRATE 312 244 9 11
METOPROLOL SUCCINATE 288 254 11 13
BISOPROLOL FUMARATE 282 236 12 133
OMEPRAZOLE 241 208 13 6
SPIRONOLACTONE 192 172 14 104
DOXAZOSIN MESYLATE 191 174 15 67
PRAVASTATIN SODIUM 180 163 16 23
PLAVIX 176 131 17 26
AMIODARONE HCL 141 115 18 94
HYDROCHLOROTHIAZIDE 138 126 19 18
PANTOPRAZOLE SODIUM 132 128 20 60
ATORVASTATIN CALCIUM 128 106 21 12
VERAPAMIL ER 124 108 22 128
NITROGLYCERIN PATCH 121 120 23 132
TERAZOSIN HCL 118 95 24 183
ISOSORBIDE MONONITRATE ER 116 82 25 28
CRESTOR 102 77 26 33
ATENOLOL 102 77 26 24
METFORMIN HCL 101 76 28 29
PROPRANOLOL HCL 101 89 28 178
POTASSIUM CHLORIDE 100 88 30 30
HYDROCODONE-ACETAMINOPHEN 83 64 S3 31 1
ALLOPURINOL 80 69 32 54
NEXIUM 78 36 33 32
EFFIENT 76 49 34 215
LOSARTAN-HYDROCHLOROTHIAZIDE 76 73 34 91
FAMOTIDINE 75 61 36 69
ZOLPIDEM TARTRATE 74 59 37 14
DIOVAN 72 58 38 65
AZITHROMYCIN 71 57 39 79
DIGOXIN 70 62 40 38
TRAMADOL HCL 69 43 41 21
LABETALOL HCL 69 66 41 156
NITROSTAT 69 52 41 70
CITALOPRAM HBR 60 53 44 34
QUINAPRIL HCL 56 44 45 226
ZETIA 55 51 46 99
PRADAXA 53 53 47 174
HEPARIN SODIUM 53 48 47 427
RAMIPRIL 53 40 47 118
TRIAMTERENE-HCTZ 52 44 50 112
LOVASTATIN 52 52 50 103
GABAPENTIN 52 38 50 7
TRICOR 51 32 53 220
JANTOVEN 50 47 54 235
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.